Literature DB >> 12571597

Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.

Peter J Mohler1, Jean-Jacques Schott, Anthony O Gramolini, Keith W Dilly, Silvia Guatimosim, William H duBell, Long-Sheng Song, Karine Haurogné, Florence Kyndt, Mervat E Ali, Terry B Rogers, W J Lederer, Denis Escande, Herve Le Marec, Vann Bennett.   

Abstract

Mutations in ion channels involved in the generation and termination of action potentials constitute a family of molecular defects that underlie fatal cardiac arrhythmias in inherited long-QT syndrome. We report here that a loss-of-function (E1425G) mutation in ankyrin-B (also known as ankyrin 2), a member of a family of versatile membrane adapters, causes dominantly inherited type 4 long-QT cardiac arrhythmia in humans. Mice heterozygous for a null mutation in ankyrin-B are haploinsufficient and display arrhythmia similar to humans. Mutation of ankyrin-B results in disruption in the cellular organization of the sodium pump, the sodium/calcium exchanger, and inositol-1,4,5-trisphosphate receptors (all ankyrin-B-binding proteins), which reduces the targeting of these proteins to the transverse tubules as well as reducing overall protein level. Ankyrin-B mutation also leads to altered Ca2+ signalling in adult cardiomyocytes that results in extrasystoles, and provides a rationale for the arrhythmia. Thus, we identify a new mechanism for cardiac arrhythmia due to abnormal coordination of multiple functionally related ion channels and transporters.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12571597     DOI: 10.1038/nature01335

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  306 in total

1.  Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing.

Authors:  David J Tester; Amber J Benton; Laura Train; Barbara Deal; Linnea M Baudhuin; Michael J Ackerman
Journal:  Am J Cardiol       Date:  2010-10-15       Impact factor: 2.778

2.  Ankyrin-B reduction enhances Ca spark-mediated SR Ca release promoting cardiac myocyte arrhythmic activity.

Authors:  Emmanuel Camors; Peter J Mohler; Donald M Bers; Sanda Despa
Journal:  J Mol Cell Cardiol       Date:  2012-03-03       Impact factor: 5.000

3.  In vivo temporal and spatial distribution of depolarization and repolarization and the illusive murine T wave.

Authors:  Gang Liu; Jason B Iden; Kay Kovithavongs; Rashida Gulamhusein; Henry J Duff; Katherine M Kavanagh
Journal:  J Physiol       Date:  2003-11-21       Impact factor: 5.182

Review 4.  Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine.

Authors:  John S Mitcheson
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 5.  The HERG K+ channel: progress in understanding the molecular basis of its unusual gating kinetics.

Authors:  Jamie I Vandenberg; Allan M Torres; Terence J Campbell; Philip W Kuchel
Journal:  Eur Biophys J       Date:  2003-09-10       Impact factor: 1.733

Review 6.  The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.

Authors:  Anthony J Baines
Journal:  Protoplasma       Date:  2010-07-29       Impact factor: 3.356

Review 7.  Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes.

Authors:  Charles Antzelevitch
Journal:  Europace       Date:  2007-09       Impact factor: 5.214

Review 8.  Autonomic aspects of arrhythmogenesis: the enduring and the new.

Authors:  Richard L Verrier; Charles Antzelevitch
Journal:  Curr Opin Cardiol       Date:  2004-01       Impact factor: 2.161

Review 9.  Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias.

Authors:  Robert S Kass; Arthur J Moss
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  Regulation of the ankyrin-B-based targeting pathway following myocardial infarction.

Authors:  Thomas J Hund; Patrick J Wright; Wen Dun; Jedidiah S Snyder; Penelope A Boyden; Peter J Mohler
Journal:  Cardiovasc Res       Date:  2008-12-14       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.